Sales & Marketing News | pharmaphorum

News

GSK's growth plans dented by Blenrep setback

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

Bayer extends CEO contract amid 'signs of success'

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

News

UK plan to lead life sciences gets mixed response

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.

News

LEO bulks up with deal for Boehringer skin drug

LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

News

Gilead's twice-yearly HIV PrEP set for wider rollout

The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.

GSK's growth plans dented by Blenrep setback

EVERSANA unveils new AI-powered pharmacovigilance suite

Bayer extends CEO contract amid 'signs of success'

UK plan to lead life sciences gets mixed response

LEO bulks up with deal for Boehringer skin drug

Gilead's twice-yearly HIV PrEP set for wider rollout

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks